As previously mentioned, recent genetic advances show a strong overlap of some NCL subtypes with later onset forms of neurodegeneration including Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia. Here, NUCLEOLIN is linked to Parkinson disease.